FindTrial
Sign In

Study on the changes of immunological maps in peripheral blood of allergic rhinitis at the onset and non-onset stage

Study on the changes of immunological maps in peripheral blood of allergic rhinitis at the onset and non-onset stage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017484
Enrollment
Unknown
Registered
2018-08-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

onset group:Nil
Non-onset group:Nil

Sponsors

Chinese Academy of Medical Sciences Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 2 years of history of allergic rhinitis with or without seasonal asthma caused by Artemisia / valerian pollen; 2. Positive test for the intradermal test of Artemisia argyi / valerian, at least ++; 3. Artemisia / valerian (w6/w22) serum sIgE> 2, can be combined with other pollen allergy; eliminate dust mites and fungal allergies, dust mites, fungal serum sIgE is 0.

Exclusion criteria

Exclusion criteria: 1. Use antihistamines within 3 days and steroids within 1 month; 2. suffering from upper and lower respiratory tract infections and other organic diseases; 3. Have a tumor or psoriasis or immunodeficiency disease.

Design outcomes

Primary

MeasureTime frame
Immune cell subset;—

Countries

China

Contacts

Public ContactSUN Jinlv

Chinese Academy of Medical Sciences Peking Union Medical College Hospital

18611382050@163.com+86 18611382050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026